How to interrogate the cellular immune system in patients with ischemic heart disease

Myocardial Ischemia: Causes, Symptoms and Treatment

Volumn , Issue , 2010, Pages 195-216

  Mohamed, Alana N ^a   Lal, Sean ^a   Ho, Joshua W K ^a,b   Brown, Angus ^a   Lui, Rodney ^a   Nguyen, Lisa ^a   Yong, Andy S C ^c   Su, Yingying ^a   Braet, Filip ^a   Dyer, Wayne ^d   Junius, Frank ^e   Cumming, Robert G ^f   Freedman, S Benedict ^c   Kritharides, Leonard ^c   Dos Remedios, Cristobal G ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CSIRO   (Australia)

^c Department of Geriatric Medicine   (Australia)

^d AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^e ST VINCENT S HOSPITAL   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Acute coronary syndrome; Antibody microarrays; Classification of coronary artery disease; Cluster of differentiation antigens; Coronary artery disease; Diagnosing coronary artery disease; Leukocytes and coronary artery disease; Limitations with current diagnostic methods; Microparticles; Microparticles and coronary artery disease; Myocardial infarction; Pathophysiology of coronary artery disease; Scanning electron microscopy; Stable angina; Unstable angina

Indexed keywords

EID: 84874844652     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (72)

1. Achar, S. A., Kundu, S. & Norcross, W. A. (2005). Diagnosis of acute coronary syndrome. Am Fam Physician, 72, 119-26.
2. Alpert, J. S., Thygesen, K., Antman, E. & Bassand, J. P. (2000). Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol, 36, 959-69.
3. Andre, P., Hartwell, D., Hrachovinpva, I., Saffaripour, S., et al. (2000). Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci, U.S.A, 97, 13835-40.
4. Belov, L., de la Vega, O., dos Remedios, C. G., Mulligan, S. P., et al. (2001). Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. Cancer Res, 61, 4483-89.
5. Belov, L., Huang, P., Barber, N., Mulligan, S. P., et al. (2003). Identification of repertoires of surface antigens on leukemias using an antibody microarray. Proteomics, 3, 2147-54.
6. Belov, L., Huang, P., Chrisp, J. S., Mulligan, S. P., et al. (2005). Screening microarrays of novel monoclonal antibodies for binding to T, B, and myeloid leukemia cells. J Immunol Methods, 305, 10-9.
7. Bennet, M. R., Evan, G. I. & Schwartz, S. M. (1995). Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest, 95, 2266-74.
8. Bernal-Mizrachi, L., Jy, W., Jimenez, J. J., Pastor, J., et. al. (2003). High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J, 145, 962-70.
9. Blake, G. J. & Ridker, P. M. (2001). Novel clinical markers of vascular wall inflammation. Circ Res, 89, 763-71.
10. Blankenberg, S., Barbaux, S. & Tiret, L. (2003). Adhesion molecules and atherosclerosis. Atherosclerosis, 170, 191-203.
11. Boulanger, C. M., Amabile, N. & Tedgui, A. (2006). Circulating microparticles: A potential prognostic marker for atherosclerotic vascular disease. Hypertension, 48, 180-6.
12. Braunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., et al. (2002). ACC/AHA guideline update for the management of patients with unstable angina and non-STsegment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation, 106, 1893-900.
13. Brown, A., Lattimore, J., McGrady, M., Sullivan, D., et al. (2008). Stable and unstable angina: identifying novel markers on circulating leukocytes. Proteomics Clin Appl, 2, 90-8.
14. Cai, H. & Harrison, D. G. (2000). Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res, 87, 840-4.
15. Calvano, S. E., Greenlee, P. G., Reid, A. M. M., Deriestal, H. F., et al. (1988). Granulocyte contamination of Ficoll-Hypaque preparations of mononuclear cells following thermal injury may lead to substantial overestimation of lymphocyte recovery. J Trauma, 28, 353-61.
16. Carbajal, E. V. & Deedwania, P. (2005). Treating non-ST-segment elevation ACS. Pros and cons of current strategies. Postgrad Med, 118, 23-32.
17. Chapman, M. J. (2005). The potential role of HDL- and LDL-cholesterol modulation in atheromatous plaque development. Curr Med Res Opin, 21, S17-22.
18. Chirinos, J. A., De Marchena, E., Ferreira, A., Alfonso, C., et al. (2006). Differential elevation of endothelial microparticles and their binding to leukocytes in acute coronary syndromes. Chest, 130, 190S.
19. Dopheide, J. F., Sester, U., Schlitt, A., Horstick, G., et al. (2007). Monocyte-derived dendritic cells of patients with coronary artery disease show an increased expression of costimulatory molecules CD40, CD80 and CD86 in vitro. Coron Artery Dis, 18, 523-31.
20. Ehrenstein, M. R., Jury, E. C. & Mauri, C. (2006). Statins for atherosclerosis as good as it gets? N Engl J Med, 352, 73-5.
21. Ellmark, P., Belov, L., Huang, P., Lee, C. S., et al. (2006). Multiplex detection of surface molecules on colorectal cancers. Proteomics, 6, 1791-1802.
22. Eriksson, E. E., Xie, X., Werr, J., Thoren, P., et al. (2001). Importance of primary capture and L-selectin-dependent secondary capture in leukocyte accumulation in inflammation and atherosclerosis in vivo. J Exp Med, 194, 205-18.
23. Gotsman, I., Sharpe, A. H. & Lichtman, A. H. (2008). T-Cell Costimulation and coinhibition in atherosclerosis. Circ Res, 103, 1220-31.
24. Hagg, D., Sjoberg, S., Hulten, L. M., Fagerberg, B., et al. (2006). Augmented levels of CD44 in macrophages from atherosclerotic subjects: A possible IL-6-CD44 feedback loop? Atherosclerosis, 190, 291-97.
25. Hak, Ł., Myśliwska, J., Więckiewicz, J., Szyndler, K., et al. (2007). NK cell compartment in patients with coronary heart disease Immun Ageing, 4, 4933.
26. Hayden, M. R. & Reidy, M. (1995). Many roads lead to atheroma. Nat Med, 1, 22-3.
27. Hosono, M., de Boer, O. J., van der Wal, C., van der Loos, C. M., et al. (2003). Increased expression of T cell activation markers (CD25, CD26, CD40L and CD69) in atherectomy specimens of patients with unstable angina and acute myocardial infarction. Atherosclerosis, 168, 73-80.
28. Ihaka, R. & Gentleman, R. R. (1996). A language for data analysis and graphics. J Comput Graph Stat, 5, 299-314.
29. Janus, E. D., Laatikainen, T., Dunbar, J. A., Kilkkinen, A., et al. (2007). Overweight, obesity and metabolic syndrome in rural southeastern Australia. Med J Aust, 187, 147-52.
30. Jonasson, L., Tompa, A. & Wikby, A. (2003). Expansion of peripheral CD81 T cells in patients with CAD: Relation to cytomegalovirus infection. J Intern Med, 254, 472-78.
31. Kahn, R., Buse, J., Ferrannini, E. & Stern, M. (2005). The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia, 48, 1684-99.
32. Kasper, D. L. & Harrison, A. (2005). Harrison’s principles of internal medicine. New York:McGraw-Hill, Medical Pub. Division.
33. Kharbanda, R. K. & Deanfield, J. E. (2001). Functions of the healthy endothelium. Coron Artery Dis, 12, 485-91.
34. Kulkarni, P. A. & Afshar-Kharghan, V. (2008). Anticomplement therapy. Biologics, 2, 671-85.
35. Lal, S. P., Brown, A., Nguyen, L., Braet, F., et al. (2009). Using antibody arrays to detect microparticles from acute coronary syndrome patients based on CD antigen expression. Mol Cell Proteomics, 8, 799-804.
36. Lal, S., Lui, R., Nguyen, L., Macdonald, P., et al. (2004). Increases in leukocyte cluster of differentiation antigen expression during cardiopulmonary bypass in patients undergoing heart transplantation. Proteomics, 4, 1918-26.
37. Lettino, M., Falcone, C. & Tavazzi, L. (2005). Therapeutic approach in patients with stable angina. Ital Heart J, 6, 1-8.
38. Li, H., Cybulsky, M. I., Gimbrone, M. A. Jr. & Libby, P. (1993). An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb, 13, 197-204.
39. Libby, P. (2002). Inflammation in atherosclerosis. Nature, 420, 868-74.
40. Liuzzo, G., Vallejo, A. N., Kopecky, S. L., Frye, R. L., et al. (2001). Molecular fingerprint of interferon-γsignaling in unstable angina. Circulation, 103, 1509-14.
41. Lui, E. T. & Karuturi, K. R. (2004). Microarrays and clinical investigations. N Engl J Med, 350, 1595-97.
42. Lusis, A. J. (2000). Atherosclerosis. Nature, 407, 233-41.
43. Maier, J. A. M., Malpuech-Brugèreb, C., Zimowskab, W., Rayssiguierb, Y., et al. (2004). Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochim Biophys Acta, 1689, 13-21.
44. Massberg, S., Schürzinger, K., Lorenz, M., Konrad, I., et al. (2005). Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia an in vivo study in mice lacking glycoprotein IIb. Circulation, 112, 1180-88.
45. McCullough, P. A. (2005). Chronic angina: new medical options for treatment. Rev Cardiovasc Med, 6, 152-61.
46. Mulvihill, N. T., Foley, J. B., Murphy, R. T., Curtin, R., et al. (2001). Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules. Heart, 85, 623-7.
47. Nissen, S. (2004). Identifying patients at risk: novel diagnostic techniques. Eur Heart J, 6, C15-C20.
48. Oksjoki, R., Kovanen, P. T. & Pentikainen, M. O. (2003). Role of complement activation in atherosclerosis. Curr Opin Lipidol, 14, 477-82.
49. Pearson, T. A. (2002). New tools for coronary risk assessment: what are their advantages and limitations? Circulation, 105, 886-92.
50. Piro, M., Giubilato, G., Pinnelli, M., Giordano, Sciacca, P., et al. (2005). Endothelium and inflammation. PanMinerva Med, 47, 75-80.
51. Ramaswamy, S., Tamayo, P., Rifkin, R., Mukherjee, S., et al. (2001). Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci, U.S.A, 98, 15149-54.
52. Reape, T. J. & Groot, P. H. E. (1999). Chemokines and atherosclerosis. Atherosclerosis, 147, 213-25.
53. Rossi, M. L., Marziliano, N., Merlini, P. A., Bramucci, E., et al. (2004). Different quantitative apoptotic traits in coronary atherosclerotic plaques from patients with stable angina pectoris and acute coronary syndromes. Circulation, 110, 1767-73.
54. Rozanski, A., Blumenthal, J. A. & Kaplan, J. (1999). Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation, 99, 2192-217.
55. Sakai, T., Inoue, S., Takei, M., Ogawa, G., et al. (2008). Role of inflammatory cells activation in growing thrombus: immunohistochemical analysis of aspiration samples in acute coronary syndrome Circulation, 118, S_581.
56. Schlitt, A., Heine, G. H., Blankenburg, S., Espinola-Klein, C., et al. (2004). CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. Thromb.Haemost, 92, 419-24.
57. Schmermund, A. & Erbel, R. (2001). Unstable coronary plaque and its relation to coronary calcium. Circulation, 104, 1682-7.
58. Schwartz, G. G. & Olsson, A. G. (2005). The case for intensive statin therapy after acute coronary syndromes. Am J Cardiol, 96, 45F-53F.
59. Scirica, B. M. & Morrow, D. A. (2004). Troponins in acute coronary syndromes. Prog Cardiovasc Dis, 47, 177-88.
60. Seifert, P. S. & Hansson, G. K. (1989). Complement receptors and regulatory proteins in human atherosclerotic lesions. Arteriosclerosis, 9, 802-11.
61. Stefanadis, C., Vavuranakis, M. & Toutouzas, P. (2003). Vulnerable plaque: the challenge to identify and treat it. J Interv Cardiol, 16, 273-80.
62. Stemme, S., Holm, J. & Hansson, G. K. (1992). T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler Thromb, 12, 206-11.
63. Su, A. I., Welsh, J. B., Sapinoso, L. M., Kern, S. G., et al. (2001). Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res, 61, 7388-93.
64. Szodoray, P. 1., Timar, O. 1., Veres, K., Der, H., et al. (2006). Th1/Th2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines - immunological alterations in acute coronary syndrome and stable coronary artery disease. Scand J Immunol, 64, 336-44.
65. Tusher, V. G., Tibshirani, R. & Chu, G. (2001). Significant analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci, U.S.A, 98, 5116-21.
66. Ursella, S., Mazzone, M., Portale, G., Testa, A., et al. (2005). How to use the C-reactive protein in cardiac disease? Minerva Cardioangiol, 53, 59-68.
67. van der Zee, P. M., Biró, E., Ko, Y., de Winter, R. J., et al. (2006). P-selectin- and CD63- exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem, 52, 657-64.
68. Vivanco, F., Martín-Ventura, J. L., Duran, M. C., Barderas, M. G., et al. (2005). Quest for novel cardiovascular biomarkers by proteomic analysis. J Proteome Res, 4, 1181-91.
69. Werner, N., Wassmann, S., Ahlers, P., Kosiol, S., et al. (2006). Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol, 26, 112-6.
70. Wong, C. K. & White, H. D. (2005). Implications of the new definition of myocardial infarction. Postgrad Med J, 81, 552-5.
71. Woolfson, A., Stebbing, J., Tom, B. D., Stoner, K. J., et al. (2005). Conservation of unique cell-surface CD antigen mosaics in HIV-1-infected individuals. Blood, 106, 1003-7.
72. Zola, H., Swart, B., Nicholson, I., Aasted, B., et al. (2005). CD molecules 2005: human cell differentiation molecules. Blood, 106, 3123-6.